Vimarsana
Biggest News Aggregation in the World

Page 8 - Initial Findings News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Initial Findings. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Initial Findings Today - Breaking & Trending Today

How to Treat: Anorexia nervosa in young people - Vimarsana News

How to Treat: Anorexia nervosa in young people

Since the onset of the COVID-19 pandemic, rates of eating disorders, particularly anorexia nervosa, have dramatically increased both in New Zealand and overseas. Young people with anorexia are most likely to present to primary care services. In this article, Hiran Thabrew offers new ideas for supporting this group of young people during the COVID-19 era

Ganciclovir eyedrops in CMV uveitis and endotheliitis - Vimarsana News

Ganciclovir eyedrops in CMV uveitis and endotheliitis

Long-term use of topical 2% ganciclovir solution is effective, safe, and applicable when commercialized ganciclovir gel is not available.

Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting - Vimarsana News

Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting - Vimarsana News

Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

Guest columnist Breanne D. Schwartz: A call for optional masking in schools - Vimarsana News

Guest columnist Breanne D. Schwartz: A call for optional masking in schools

My children are too young now to remember life before the COVID-19 pandemic, but every day that they attend school in Northampton amid a sea of masked faces, my heart breaks for them. It breaks for all that has been lost over the last two years,...